Hepatic impairment Zolpidem tartrate prolonged-launch tablets weren't studied in people with hepatic impairment. The pharmacokinetics of an instantaneous-release formulation of zolpidem tartrate in 8 sufferers with Persistent hepatic insufficiency was in comparison to leads to healthful topics. Following a single 20-mg oral zolpidem tartrate dose, indicate C max and AUC https://keeganwjtir.pages10.com/a-review-of-bensedin-10mg-effects-68134163